Cross-sectional study of aortic valve calcification and cardiovascular risk factors in older Danish men.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
10 2021
Historique:
received: 28 01 2021
accepted: 27 06 2021
pubmed: 12 8 2021
medline: 15 12 2021
entrez: 11 8 2021
Statut: ppublish

Résumé

Aortic valve calcification (AVC) and coronary artery calcification (CAC) are predictors of cardiovascular disease (CVD), presumably sharing risk factors. Our objectives were to determine the prevalence and extent of AVC in a large population of men aged 60-74 years and to assess the association between AVC and cardiovascular risk factors including CAC and biomarkers. Participants from the DANish CArdioVAscular Screening and intervention trial (DANCAVAS) with AVC and CAC scores and without previous valve replacement were included in the study. Calcification scores were calculated on non-contrast CT scans. Cardiovascular risk factors were self-reported, measured or both, and further explored using descriptive and regression analysis for AVC association. 14 073 men aged 60-74 years were included. The AVC scores ranged from 0 to 9067 AU, with a median AVC of 6 AU (IQR 0-82). In 8156 individuals (58.0%), the AVC score was >0 and 215 (1.5%) had an AVC score ≥1200. In the regression analysis, all cardiovascular risk factors were associated with AVC; however, after inclusion of CAC ≥400, only age (ratio of expected counts (REC) 1.07 (95% CI 1.06 to 1.09)), hypertension (REC 1.24 (95% CI 1.09 to 1.41)), obesity (REC 1.34 (95% CI 1.20 to 1.50)), known CVD (REC 1.16 (95% CI 1.03 to 1.31)) and serum phosphate (REC 2.25 (95% CI 1.66 to 3.10) remained significantly associated, while smoking, diabetes, hyperlipidaemia, estimated glomerular filtration rate and serum calcium were not. AVC was prevalent in the general population of men aged 60-74 years and was significantly associated with all modifiable cardiovascular risk factors, but only selectively after adjustment for CAC ≥400 AU. NCT03946410 and ISRCTN12157806.

Identifiants

pubmed: 34376488
pii: heartjnl-2021-319023
doi: 10.1136/heartjnl-2021-319023
doi:

Banques de données

ClinicalTrials.gov
['NCT03946410']
ISRCTN
['ISRCTN12157806']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1536-1543

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Lida Khurrami (L)

Department of Cardiology, Odense University Hospital, Odense, Denmark drlkdk@gmail.com.

Jacob Eifer Møller (JE)

Department of Cardiology, Odense University Hospital, Odense, Denmark.
Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Jes Sanddal Lindholt (JS)

Department of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark.
Cardiovascular Centre of Excellence (CAVAC), Odense, Denmark.
University of Southern Denmark, Odense, Denmark.

Grazina Urbonaviciene (G)

Department of Cardiology, Regional Hospital of Central Jutland, Silkeborg, Denmark.

Flemming Hald Steffensen (FH)

Department of Cardiology, Lillebaelt Hospital, Vejle, Denmark.

Jess Lambrechtsen (J)

Department of Cardiology, Odense University Hospital, Odense, Denmark.

Marek Karon (M)

Department of Medicine, Nykøbing Falster Hospital, Region Zealand, Denmark.

Lars Frost (L)

Department of Cardiology, Regional Hospital of Central Jutland, Silkeborg, Denmark.

Martin Busk (M)

Department of Cardiology, Lillebaelt Hospital, Vejle, Denmark.

Kenneth Egstrup (K)

Department of Cardiology, Odense University Hospital, Odense, Denmark.

Maise Høigaard Fredgart (MH)

Department of Cardiology, Odense University Hospital, Odense, Denmark.

Axel Cosmus Pyndt Diederichsen (ACP)

Department of Cardiology, Odense University Hospital, Odense, Denmark.
Cardiovascular Centre of Excellence (CAVAC), Odense, Denmark.
University of Southern Denmark, Odense, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH